Is Oncolytics Biotech Inc. (ONCY) a Buy, Sell, or Hold?
NASDAQ : ONCY
Oncolytics Biotech Inc.
$0.8533 USD
-$0.03 (-3.37%)
- Volume
- 1.22M
- Average Volume
- 1.45M
- Market Capitalization
- $85.64M
- P/E Ratio
- -3.55
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $1.51
- Year Low
- $0.77
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.38
Insider Activity Summary (Last 12 Months)
Insiders Buying
14
Insiders Selling
0
Amount of Insider Selling
-$
ONCY Insider Buying/Selling by Quarter
ONCY Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| McAdory John Bearden | officer: Chief Operating Officer | 2026-06-01 | 0.97 | 2026-06-03 | |
| Glover Stephen C. | director: | 2026-06-01 | 0 | 2026-06-03 | |
| Parsons James T. | director | 2026-03-11 | P-Purchase | 1.03 | 2026-03-13 |
| Kelly Jared | director, officer: Chief Executive Officer | 2026-03-12 | P-Purchase | 0.96 | 2026-03-13 |
| Kelly Jared | director, officer: Chief Executive Officer | 2026-02-12 | P-Purchase | 0.842 | 2026-02-13 |
| Kelly Jared | director, officer: Chief Executive Officer | 2026-02-11 | P-Purchase | 0.836 | 2026-02-13 |
| Look Kirk | officer: Chief Financial Officer | 2026-02-12 | P-Purchase | 0.842 | 2026-02-13 |
| Pisano Wayne | director | 2026-02-12 | P-Purchase | 0.8446 | 2026-02-13 |
| Heineman Thomas Charles | officer: Chief Medical Officer | 2026-02-12 | P-Purchase | 0.827 | 2026-02-13 |
| Brown Deborah Margaret | director | 2026-02-12 | P-Purchase | 0.8496 | 2026-02-13 |
| Hagerman Allison | officer: VP, Product Development | 2026-02-12 | P-Purchase | 0.8298 | 2026-02-13 |
| Seizinger Bernd R. | director | 2026-02-12 | P-Purchase | 0.8466 | 2026-02-13 |
| Seizinger Bernd R. | director | 2026-02-11 | P-Purchase | 0.8265 | 2026-02-13 |
| Aromando Andrew | officer: Chief Business Officer | 2026-02-11 | P-Purchase | 0.8587 | 2026-02-13 |
| Andrews Patricia S | director | 2026-02-12 | P-Purchase | 0.8557 | 2026-02-13 |
| Seizinger Bernd R. | director | 2026-01-16 | P-Purchase | 1.0377 | 2026-01-20 |
| Look Kirk | officer: Chief Financial Officer | 2026-01-01 | 0 | 2026-01-02 | |
| Look Kirk | officer: Chief Financial Officer | 2026-01-01 | 2.66 | 2026-01-02 | |
| Look Kirk | officer: Chief Financial Officer | 2026-01-01 | 3.4 | 2026-01-02 | |
| Look Kirk | officer: Chief Financial Officer | 2026-01-01 | 2.31 | 2026-01-02 | |
| Look Kirk | officer: Chief Financial Officer | 2026-01-01 | 2.76 | 2026-01-02 | |
| Look Kirk | officer: Chief Financial Officer | 2026-01-01 | 1.91 | 2026-01-02 | |
| Look Kirk | officer: Chief Financial Officer | 2026-01-01 | 0.99 | 2026-01-02 | |
| Look Kirk | officer: Chief Financial Officer | 2026-01-01 | 1.13 | 2026-01-02 | |
| Look Kirk | officer: Chief Financial Officer | 2026-01-01 | 1.08 | 2026-01-02 | |
| Andrews Patricia S | director | 2026-01-01 | 0 | 2026-01-02 | |
| Andrews Patricia S | director | 2026-01-01 | 1.76 | 2026-01-02 | |
| Andrews Patricia S | director | 2026-01-01 | 1.08 | 2026-01-02 | |
| Kelly Jared | director, officer: Chief Executive Officer | 2026-01-01 | 0 | 2026-01-02 | |
| Kelly Jared | director, officer: Chief Executive Officer | 2026-01-01 | 1.08 | 2026-01-02 | |
| Kelly Jared | director, officer: Chief Executive Officer | 2026-01-01 | 0.99 | 2026-01-02 | |
| Kelly Jared | director, officer: Chief Executive Officer | 2026-01-01 | 0.57 | 2026-01-02 | |
| Hagerman Allison | officer: VP, Product Development | 2026-01-01 | 0 | 2026-01-02 | |
| Hagerman Allison | officer: VP, Product Development | 2026-01-01 | 2.31 | 2026-01-02 | |
| Hagerman Allison | officer: VP, Product Development | 2026-01-01 | 2.76 | 2026-01-02 | |
| Hagerman Allison | officer: VP, Product Development | 2026-01-01 | 1.91 | 2026-01-02 | |
| Hagerman Allison | officer: VP, Product Development | 2026-01-01 | 1.13 | 2026-01-02 | |
| Hagerman Allison | officer: VP, Product Development | 2026-01-01 | 2.66 | 2026-01-02 | |
| Hagerman Allison | officer: VP, Product Development | 2026-01-01 | 3.4 | 2026-01-02 | |
| Hagerman Allison | officer: VP, Product Development | 2026-01-01 | 1.08 | 2026-01-02 | |
| Hagerman Allison | officer: VP, Product Development | 2026-01-01 | 0.99 | 2026-01-02 | |
| Heineman Thomas Charles | officer: Chief Medical Officer | 2026-01-01 | 0 | 2026-01-02 | |
| Heineman Thomas Charles | officer: Chief Medical Officer | 2026-01-01 | 1.08 | 2026-01-02 | |
| Heineman Thomas Charles | officer: Chief Medical Officer | 2026-01-01 | 0.99 | 2026-01-02 | |
| Heineman Thomas Charles | officer: Chief Medical Officer | 2026-01-01 | 3.4 | 2026-01-02 | |
| Heineman Thomas Charles | officer: Chief Medical Officer | 2026-01-01 | 1.91 | 2026-01-02 | |
| Heineman Thomas Charles | officer: Chief Medical Officer | 2026-01-01 | 2.76 | 2026-01-02 | |
| Heineman Thomas Charles | officer: Chief Medical Officer | 2026-01-01 | 1.13 | 2026-01-02 | |
| Heineman Thomas Charles | officer: Chief Medical Officer | 2026-01-01 | 2.31 | 2026-01-02 | |
| Holtham Angela | director | 2026-01-01 | 0 | 2026-01-02 | |
| Holtham Angela | director | 2026-01-01 | 0 | 2026-01-02 | |
| Holtham Angela | director | 2026-01-01 | 1.08 | 2026-01-02 | |
| Holtham Angela | director | 2026-01-01 | 2.76 | 2026-01-02 | |
| Holtham Angela | director | 2026-01-01 | 1.13 | 2026-01-02 | |
| Holtham Angela | director | 2026-01-01 | 3.4 | 2026-01-02 | |
| Holtham Angela | director | 2026-01-01 | 1.14 | 2026-01-02 | |
| Parsons James T. | director | 2026-01-01 | 0 | 2026-01-02 | |
| Parsons James T. | director | 2026-01-01 | 1.13 | 2026-01-02 | |
| Parsons James T. | director | 2026-01-01 | 1.08 | 2026-01-02 | |
| Parsons James T. | director | 2026-01-01 | 2.76 | 2026-01-02 | |
| Parsons James T. | director | 2026-01-01 | 1.14 | 2026-01-02 | |
| Seizinger Bernd R. | director | 2026-01-01 | 0 | 2026-01-02 | |
| Seizinger Bernd R. | director | 2026-01-01 | 1.14 | 2026-01-02 | |
| Seizinger Bernd R. | director | 2026-01-01 | 3.4 | 2026-01-02 | |
| Seizinger Bernd R. | director | 2026-01-01 | 2.76 | 2026-01-02 | |
| Seizinger Bernd R. | director | 2026-01-01 | 1.13 | 2026-01-02 | |
| Seizinger Bernd R. | director | 2026-01-01 | 1.08 | 2026-01-02 | |
| Pisano Wayne | director | 2026-01-01 | 0 | 2026-01-02 | |
| Pisano Wayne | director | 2026-01-01 | 1.13 | 2026-01-02 | |
| Pisano Wayne | director | 2026-01-01 | 1.14 | 2026-01-02 | |
| Pisano Wayne | director | 2026-01-01 | 1.08 | 2026-01-02 | |
| Pisano Wayne | director | 2026-01-01 | 2.76 | 2026-01-02 | |
| Pisano Wayne | director | 2026-01-01 | 3.4 | 2026-01-02 | |
| Brown Deborah Margaret | director | 2026-01-01 | 0 | 2026-01-02 | |
| Brown Deborah Margaret | director | 2026-01-01 | 3.4 | 2026-01-02 | |
| Brown Deborah Margaret | director | 2026-01-01 | 1.13 | 2026-01-02 | |
| Brown Deborah Margaret | director | 2026-01-01 | 2.76 | 2026-01-02 | |
| Brown Deborah Margaret | director | 2026-01-01 | 1.14 | 2026-01-02 | |
| Brown Deborah Margaret | director | 2026-01-01 | 1.08 | 2026-01-02 | |
| Brown Deborah Margaret | director | 2026-01-01 | 5.42 | 2026-01-02 | |
| Aromando Andrew | officer: Chief Business Officer | 2026-01-01 | 0 | 2026-01-02 | |
| Aromando Andrew | officer: Chief Business Officer | 2026-01-01 | 1.08 | 2026-01-02 | |
| Aromando Andrew | officer: Chief Business Officer | 2026-01-01 | 0.93 | 2026-01-02 | |
| Aromando Andrew | officer: Chief Business Officer | 2026-01-01 | 0.99 | 2026-01-02 | |
| RIGBY JONATHAN | director | 2026-01-01 | 0 | 2026-01-02 | |
| RIGBY JONATHAN | director | 2026-01-01 | 1.08 | 2026-01-02 | |
| RIGBY JONATHAN | director | 2026-01-01 | 2.76 | 2026-01-02 | |
| RIGBY JONATHAN | director | 2026-01-01 | 1.13 | 2026-01-02 | |
| RIGBY JONATHAN | director | 2026-01-01 | 1.84 | 2026-01-02 |